RxDoctor Payments Data

Heather Shelton, MD

Family Medicine · Florence, SCNPI 1932132693

Payments from drug & device makers

$7,935in general payments, 2019–2025

Across 509 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$824
  • Lilly USA, LLC$770
  • AstraZeneca$693
  • Amgen$639
  • Pfizer$604
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$7,81799%
  • Education$1181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,935 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$112,766
Medicare patients
315
Services billed
3,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$66,477
OzempicSemaglutide49$57,960
EliquisApixaban33$46,395
FarxigaDapagliflozin Propanediol50$35,854
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$30,594
MounjaroTirzepatide23$21,734
MyrbetriqMirabegron20$15,665
VraylarCariprazine Hcl11$15,281
JanuviaSitagliptin Phosphate21$14,381
Tresiba Flextouch U-200Insulin Degludec13$12,599
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$11,272
Repatha SureclickEvolocumab14$10,713
TrulicityDulaglutide11$10,526
TrulancePlecanatide12$6,941
Atorvastatin Calcium327$3,626

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$101$66,47759 claims
Novo NordiskOzempic$824$57,96049 claims
AstraZenecaFarxiga, Breztri Aerosphere$693$47,12664 claims
PfizerEliquis$604$46,39533 claims
Lilly USA, LLCMounjaro, Trulicity$770$32,26034 claims
GSKTrelegy Ellipta$160$30,59442 claims
AbbVieVraylar, Synthroid$2,248$16,97531 claims
Astellas Pharma US IncMyrbetriq$100$15,66520 claims
MerckJanuvia$142$14,38121 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$131$6,94112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →